164 results
Page 6 of 9
DRS/A
EX-10.40
8uatrwdv7iky66dod2m1
14 Oct 16
Draft registration statement (amended)
12:00am
S-1
EX-10.39
g5tr 9hwybiptvoy6
14 Oct 16
IPO registration
12:00am
S-1
EX-10.40
9drl tzxpqdt7mv
14 Oct 16
IPO registration
12:00am
S-1
EX-10.38
2v8v i2cr2ed3igfn7u
14 Oct 16
IPO registration
12:00am
DRS/A
EX-10.38
8dz8jsbmp
14 Oct 16
Draft registration statement (amended)
12:00am
S-1
EX-10.36
edptwr2 376
14 Oct 16
IPO registration
12:00am
DRS/A
EX-10.31
ce80u7 aw
14 Oct 16
Draft registration statement (amended)
12:00am
DRS/A
EX-10.35
24k55fenf
14 Oct 16
Draft registration statement (amended)
12:00am
DRS/A
EX-10.39
ljxkvwg6
14 Oct 16
Draft registration statement (amended)
12:00am
DRS/A
EX-10.36
yq1d bxl0o8rjnk
14 Oct 16
Draft registration statement (amended)
12:00am
S-1
EX-10.35
eqwxjv2w8c7wt
14 Oct 16
IPO registration
12:00am
S-1
EX-10.31
sg0dj
14 Oct 16
IPO registration
12:00am
DRS/A
EX-10.35
wmaux
25 Aug 16
Draft registration statement (amended)
12:00am
DRS/A
EX-10.36
4typ7qa0msf
25 Aug 16
Draft registration statement (amended)
12:00am
DRS/A
EX-10.31
0en55b25abhb9oy9yta9
25 Aug 16
Draft registration statement (amended)
12:00am
8-K
EX-10.1
km594d4u4c
20 May 16
Other Events
12:00am
8-K
EX-10.1
z1euxc9
21 Apr 16
Immune Therapeutics signs Binding Letter of Intent to Acquire Chinese CAR-T Technology and Clinical Data
12:00am
8-K
EX-10.1
fncaef5wpym
4 Dec 15
Financial Statements and Exhibits
12:00am
8-K
EX-10.1
anv9v64m
21 May 15
Entry into a Material Definitive Agreement
12:00am